Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Impaired reward-related learning signals in remitted unmedicated patients with recurrent depression.

Geugies H, Mocking RJT, Figueroa CA, Groot PFC, Marsman JC, Servaas MN, Steele JD, Schene AH, Ruhé HG.

Brain. 2019 Aug 1;142(8):2510-2522. doi: 10.1093/brain/awz167.

PMID:
31280309
2.

Tapering of SSRI treatment to mitigate withdrawal symptoms.

Ruhe HG, Horikx A, van Avendonk MJP, Groeneweg BF, Woutersen-Koch H; Discontinuation of Antidepressants Taskforce.

Lancet Psychiatry. 2019 Jul;6(7):561-562. doi: 10.1016/S2215-0366(19)30182-8. No abstract available.

PMID:
31230677
3.

Attentional control, rumination and recurrence of depression.

Figueroa CA, DeJong H, Mocking RJT, Fox E, Rive MM, Schene AH, Stein A, Ruhé HG.

J Affect Disord. 2019 May 30;256:364-372. doi: 10.1016/j.jad.2019.05.072. [Epub ahead of print]

PMID:
31207560
4.

The decision tool unipolar depression (DTUD): a new measure to facilitate the early identification of patients with major depressive disorder in need of highly specialized care.

van Krugten FCW, Goorden M, van Balkom AJLM, van Oppen P, Ruhé HG, van Schaik DJF, Brouwer WBF, Hakkaart-van Roijen L; Decision Tool Unipolar Depression Consortium.

BMC Psychiatry. 2019 Jun 11;19(1):179. doi: 10.1186/s12888-019-2165-9.

5.

Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis.

Shinohara K, Efthimiou O, Ostinelli EG, Tomlinson A, Geddes JR, Nierenberg AA, Ruhe HG, Furukawa TA, Cipriani A.

BMJ Open. 2019 May 19;9(5):e027574. doi: 10.1136/bmjopen-2018-027574.

6.

Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling.

van Rooijen G, van Rooijen M, Maat A, Vermeulen JM, Meijer CJ, Ruhé HG, de Haan L; GROUP investigators; Genetic Risk and Outcome of Psychosis investigators:, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Amelsvoort T, van Haren NE, van Os J, van Winkel R.

Schizophr Res. 2019 Jun;208:82-89. doi: 10.1016/j.schres.2019.04.011. Epub 2019 Apr 29.

PMID:
31047723
7.

[Reaction on 'Persistant underuse of ECT for persistant depressive disorder?']

Scheepens DS, van Waarde JA, Lok A, Zantvoord JB, de Pont BJHB, Ruhé HG, Denys DAJP, van Wingen GA.

Tijdschr Psychiatr. 2019;61(4):287. Dutch.

8.

Emotional Biases and Recurrence in Major Depressive Disorder. Results of 2.5 Years Follow-Up of Drug-Free Cohort Vulnerable for Recurrence.

Ruhe HG, Mocking RJT, Figueroa CA, Seeverens PWJ, Ikani N, Tyborowska A, Browning M, Vrijsen JN, Harmer CJ, Schene AH.

Front Psychiatry. 2019 Mar 28;10:145. doi: 10.3389/fpsyt.2019.00145. eCollection 2019.

9.

Altered ability to access a clinically relevant control network in patients remitted from major depressive disorder.

Figueroa CA, Cabral J, Mocking RJT, Rapuano KM, van Hartevelt TJ, Deco G, Expert P, Schene AH, Kringelbach ML, Ruhé HG.

Hum Brain Mapp. 2019 Jun 15;40(9):2771-2786. doi: 10.1002/hbm.24559. Epub 2019 Mar 12.

10.

[The care standard 'Depressive disorders'].

Spijker J, Meeuwissen JAC, Aalbers S, van Avendonk M, van Bon M, Huson A, van der Lande J, Oudijk M, Bockting C, Ruhé HG.

Tijdschr Psychiatr. 2019;61(2):112-120. Dutch.

11.

Distinct temporal brain dynamics in bipolar disorder and schizophrenia during emotion regulation.

Zhang L, Ai H, Opmeer EM, Marsman JC, van der Meer L, Ruhé HG, Aleman A, van Tol MJ.

Psychol Med. 2019 Feb 18:1-9. doi: 10.1017/S0033291719000217. [Epub ahead of print]

PMID:
30773147
12.

Design and methods of the 'monitoring outcomes of psychiatric pharmacotherapy' (MOPHAR) monitoring program - a study protocol.

Simoons M, Ruhé HG, van Roon EN, Schoevers RA, Bruggeman R, Cath DC, Muis D, Arends J, Doornbos B, Mulder H.

BMC Health Serv Res. 2019 Feb 14;19(1):125. doi: 10.1186/s12913-019-3951-2.

13.

[Electroconvulsion therapy for persistent depression in the Netherlands; very low application rate].

Scheepens DS, van Waarde JA, Lok A, Zantvoord JB, de Pont BJHB, Ruhé HG, Denys DAJP, van Wingen GA.

Tijdschr Psychiatr. 2019;61(1):16-21. Dutch.

14.

Metabolic Syndrome at an Outpatient Clinic for Bipolar Disorders: A Case for Systematic Somatic Monitoring.

Simoons M, Mulder H, Doornbos B, Raats PCC, Bruggeman R, Cath DC, Schoevers RA, Ruhé HG, van Roon EN.

Psychiatr Serv. 2019 Feb 1;70(2):143-146. doi: 10.1176/appi.ps.201800121. Epub 2018 Dec 10.

PMID:
30526344
15.

Predicting clinical course in major depressive disorder: The association between DM-TRD score and symptom severity over time in 1115 outpatients.

van Dijk DA, van den Boogaard TM, Deen ML, Spijker J, Ruhé HG, Peeters FPML.

Depress Anxiety. 2019 Apr;36(4):345-352. doi: 10.1002/da.22865. Epub 2018 Nov 26.

PMID:
30474901
16.

Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression.

Ter Horst DM, Schene AH, Figueroa CA, Assies J, Lok A, Bockting CLH, Ruhé HG, Mocking RJT.

Psychoneuroendocrinology. 2019 Feb;100:203-212. doi: 10.1016/j.psyneuen.2018.10.012. Epub 2018 Oct 19.

PMID:
30388594
17.

Correction to: Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder.

Grootens KP, Meijer A, Hartong EG, Doornbos B, Roberto Bakker P, Al Hadithy A, Hoogerheide KN, Overmeire F, Marijnissen RM, Ruhe HG.

Eur J Clin Pharmacol. 2018 Nov;74(11):1491. doi: 10.1007/s00228-018-2556-8.

PMID:
30218112
18.

Differential relations of suicidality in depression to brain activation during emotional and executive processing.

Ai H, van Tol MJ, Marsman JC, Veltman DJ, Ruhé HG, van der Wee NJA, Opmeer EM, Aleman A.

J Psychiatr Res. 2018 Oct;105:78-85. doi: 10.1016/j.jpsychires.2018.08.018. Epub 2018 Aug 14.

PMID:
30212727
19.

[Sexual dysfunction as a side effect of medication].

van Berkel A, Seldenrijk A, Knegtering H, Bakker PR, Ruhé HG, Kramers C.

Ned Tijdschr Geneeskd. 2018 Sep 5;162. pii: D2749. Dutch. No abstract available.

PMID:
30209903
20.

Effectiveness of psychotherapy for treatment-resistant depression: a meta-analysis and meta-regression.

van Bronswijk S, Moopen N, Beijers L, Ruhe HG, Peeters F.

Psychol Med. 2019 Feb;49(3):366-379. doi: 10.1017/S003329171800199X. Epub 2018 Aug 24.

PMID:
30139408

Supplemental Content

Loading ...
Support Center